Clordisys Solutions

Name

Clordisys Solutions

Legal name

ClorDiSys Solutions, LLC

Website

https://clordisys.com

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Contract Sterilization Services

akta.pro primary industry

Sterilization Services & Contract Reprocessing (ETO/Gamma/E-beam providers) (HLAHANAB)

Keywords

• Contract sterilization services
• Chlorine dioxide sterilization
• Medical device sterilization
• Pharmaceutical sterilization
• Ethylene oxide alternatives

Headquarters

HQ city

Somerville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Contract Sterilization Services: FDA-registered, ISO 13485-certified contract sterilization facility providing chlorine dioxide gas sterilization for medical devices, pharmaceuticals, and combination products. Services include initial assessment and consultation, production processing with real-time monitoring and batch records, regulatory support for FDA submissions and international pathways, and certificates of sterilization for every processed lot. Same-day processing available with 24/7 capabilities.
2. EO to CD Conversion Consulting: Conversion services helping customers transition from ethylene oxide to chlorine dioxide, leveraging existing infrastructure while upgrading to superior CD technology through proprietary conversion methods
3. Material Compatibility Testing: Testing services evaluating material compatibility with chlorine dioxide gas under worst-case sterilization conditions including extended exposure times and elevated concentrations, evaluating physical, chemical, and functional properties to support FDA submissions

Go-to-market motion1 record

Distribution channels1 record

Marketing channels6 records

Core offering

Clordisys Solutions provides FDA-registered, ISO 13485-certified contract sterilization services using its proprietary Pure CD (chlorine dioxide) gas technology for medical devices, pharmaceuticals, and combination products. The service delivers ambient temperature sterilization with no toxic residuals, same-day processing, and full regulatory pathway support. The company also offers EO to CD conversion services enabling facilities to transition from ethylene oxide to chlorine dioxide, plus material compatibility testing.

Product overview

Clordisys Solutions is a provider of chlorine dioxide gas contract sterilization services, built around its proprietary Pure CD Technology. The core offering is its FDA-registered, ISO 13485-certified contract sterilization facility, supplemented by EO to CD Conversion Services that allow facilities to transition from ethylene oxide. The company serves three primary industry segments: Medical Device Sterilization, Pharmaceutical Sterilization, and Combination Device Sterilization. The portfolio is unified by the Pure CD Technology platform, which provides ambient temperature, residue-free sterilization as an alternative to ethylene oxide, irradiation, and other gas sterilization methods.

Differentiator

Problem solved

Functional benefit

Products and services

• Contract Sterilization Services FDA-registered, ISO 13485-certified contract sterilization facility offering chlorine dioxide gas sterilization for complex medical devices, pharmaceuticals, and combination products with faster processing times and no toxic residuals. Services include initial assessment and consultation, production processing with real-time monitoring and batch records, regulatory support for FDA submissions, and certificates of sterilization for every processed lot. Same-day processing available with 24/7 capabilities.
• EO to CD Conversion Services Conversion services enabling facilities to leverage existing ethylene oxide infrastructure while upgrading to chlorine dioxide technology through a patented conversion system. Helps sterilization facilities transition from EO to CD with reduced capital investment.
• Material Compatibility Testing Testing services evaluating material compatibility with chlorine dioxide gas under worst-case sterilization conditions including extended exposure times and elevated concentrations, assessing physical, chemical, and functional properties to support FDA submissions.
• Medical Device Sterilization Specialized sterilization services for complex medical devices including surgical instruments, implants, electronic devices, and smart implants with embedded electronics that cannot withstand traditional sterilization methods such as heat, radiation, or ethylene oxide.
• Pharmaceutical Sterilization Contract sterilization services for active pharmaceutical ingredients, powders, crystalline materials, biologics, lyophilized excipients, prefilled syringes, autoinjectors, inhalation devices, transdermal delivery systems, implantable drug pumps, controlled-release systems, and other temperature-sensitive pharmaceutical compounds.
• Combination Device Sterilization Sterilization services for combination products such as drug-eluting implants, smart auto-injectors, cardiovascular stents with therapeutic coatings, orthopedic implants with antimicrobial surfaces, catheter systems with drug-delivery capabilities, insulin pens with electronic monitoring, and connected packaging with patient communication systems requiring preservation of both drug stability and device functionality.

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Sterigenics (Sotera Health): Largest global contract sterilization services provider (EO, gamma, E-beam) and the dominant incumbent Clordisys directly competes against. Both serve medical device and pharmaceutical manufacturers with validated sterilization under FDA/ISO frameworks.
• Noxilizer: Nitrogen dioxide (NO2) sterilization technology provider and the closest direct alternative-modality competitor to Clordisys' chlorine dioxide. Both target the same EO-alternative use cases for medical devices and pharma.
• Cosmed Group: Mid-sized contract sterilization services provider (EO, gamma, E-beam) serving medical device and pharmaceutical customers. Comparable business model and customer base to Clordisys, though focused on conventional modalities.
• E-BEAM Services: Contract electron beam sterilization services provider for medical devices, pharmaceuticals, and food. Competes with Clordisys for alternative-modality share but is limited to radiation-compatible products.
• Pacific Bio-Material Management: Contract sterilization services provider offering EO, gamma, and E-beam modalities to medical device manufacturers. Smaller-scale competitor with comparable service model and customer focus.
• Andersen Sterilizers: Provider of dry-heat and alternative sterilization equipment and contract services for medical devices and pharmaceuticals. Competes in the broader alternative-modality segment for customers seeking non-EO, non-radiation solutions.

Broad incumbents

• STERIS: Major sterilization services and equipment provider offering EO, gamma, and VHP modalities across a broad portfolio. Competes with Clordisys for contract sterilization work and has the scale to invest in alternative modalities if the EO transition accelerates.
• Getinge: Large medical device and sterilization equipment/services company with contract sterilization operations and a broad portfolio. Competes with Clordisys primarily as an incumbent with deeper installed base and capital resources.

Regional players

• Medistri: Swiss-headquartered contract sterilization and laboratory services provider serving European medical device and pharma customers. Similar EO and gamma service profile but geographically complementary rather than overlapping with Clordisys.

Others

• Allentown LLC: Clordisys' parent company since December 2023, providing complementary decontamination and sterilization equipment (caging, racks, washers) primarily for the research and vivarium segments. Parent owns Clordisys but the two serve distinct adjacent markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCffif_ndVnB5YrrJw7b9j-Q?feature=watch
• LinkedInlinkedin.com/company/clordisys-solutions-inc
• Xx.com/ClorDiSys

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clordisys Solutions